| 1 | [SID81065467] | Active | EC50 | 1.297 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype protein [AID2019, Type: confirmatory] | cell division cycle 42 (GTP binding protein, 25kDa) [Homo sapiens] [gi:56202836] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 81065467 | | CID | 42628053 | | Outcome | Active | | EC50 | 1.297 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype protein | | AID | 2019 | | BioAssay type | confirmatory | | Target | cell division cycle 42 (GTP binding protein, 25kDa) [Homo sapiens] [gi:56202836] | | PubMed | | | Data Table |  |
|
| 2 | [SID87349043] | Active | Potency | 1.2995 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Active | | Potency | 1.2995 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 3 | [SID87349043] | Active | Potency | 2.0596 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Active | | Potency | 2.0596 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 4 | [SID81065467] | Active | EC50 | 2.08 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 activated mutant [AID2020, Type: confirmatory] | cell division cycle 42 (GTP binding protein, 25kDa) [Homo sapiens] [gi:56202836] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 81065467 | | CID | 42628053 | | Outcome | Active | | EC50 | 2.08 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 activated mutant | | AID | 2020 | | BioAssay type | confirmatory | | Target | cell division cycle 42 (GTP binding protein, 25kDa) [Homo sapiens] [gi:56202836] | | PubMed | | | Data Table |  |
|
| 5 | [SID87349043] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID87349043] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 7 | [SID87349043] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 8 | [SID87349043] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis [AID588726, Type: screening] | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis | | AID | 588726 | | BioAssay type | screening | | Target | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] | | PubMed | | | Data Table |  |
|
| 9 | [SID87349043] | Active | | | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity [AID488896, Type: screening] | Scarb1 gene product [Mus musculus] [gi:14389423] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Active | | BioAssay | HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488896 | | BioAssay type | screening | | Target | Scarb1 gene product [Mus musculus] [gi:14389423] | | PubMed | | | Data Table |  |
|
| 10 | [SID87349043] | Active | | | HTS Assay for Peg3 Promoter Inhibitors [AID588405, Type: screening] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Active | | BioAssay | HTS Assay for Peg3 Promoter Inhibitors | | AID | 588405 | | BioAssay type | screening | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 11 | [SID87349043] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 12 | [SID87349043] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 13 | [SID81065467] | Inactive | EC50 | 0.141 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab7 wildtype [AID2041, Type: confirmatory] | GTP-binding protein (rab7) [Canis lupus familiaris] [gi:164058] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 81065467 | | CID | 42628053 | | Outcome | Inactive | | EC50 | 0.141 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab7 wildtype | | AID | 2041 | | BioAssay type | confirmatory | | Target | GTP-binding protein (rab7) [Canis lupus familiaris] [gi:164058] | | PubMed | | | Data Table |  |
|
| 14 | [SID87349043] | Inactive | Potency | 5.6234 | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy [AID624291, Type: confirmatory] | Glycoprotein hormones alpha chain [gi:121312] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | Potency | 5.6234 [uM] | | BioAssay | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy | | AID | 624291 | | BioAssay type | confirmatory | | Target | Glycoprotein hormones alpha chain [gi:121312] | | PubMed | | | Data Table |  |
|
| 15 | [SID87349043] | Inactive | Potency | 10 | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen [AID624418, Type: confirmatory] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | Potency | 10 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen | | AID | 624418 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID87349043] | Inactive | Potency | 10 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 17 | [SID87349043] | Inactive | Potency | 17.7828 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | Potency | 17.7828 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 18 | [SID87349043] | Inactive | Potency | 17.7828 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | Potency | 17.7828 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 19 | [SID81065467] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype [AID2045, Type: confirmatory] | Ras-related protein Rab-2 [gi:46577642] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 81065467 | | CID | 42628053 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype | | AID | 2045 | | BioAssay type | confirmatory | | Target | Ras-related protein Rab-2 [gi:46577642] | | PubMed | | | Data Table |  |
|
| 20 | [SID81065467] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 wildtype [AID2055, Type: confirmatory] | Rac1 protein [Homo sapiens] [gi:8574038] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 81065467 | | CID | 42628053 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 wildtype | | AID | 2055 | | BioAssay type | confirmatory | | Target | Rac1 protein [Homo sapiens] [gi:8574038] | | PubMed | | | Data Table |  |
|
| 21 | [SID81065467] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 wildtype [AID2055, Type: confirmatory] | Rac1 protein [Homo sapiens] [gi:8574038] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 81065467 | | CID | 42628053 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 wildtype | | AID | 2055 | | BioAssay type | confirmatory | | Target | Rac1 protein [Homo sapiens] [gi:8574038] | | PubMed | | | Data Table |  |
|
| 22 | [SID81065467] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 activated mutant [AID2048, Type: confirmatory] | Rac1 protein [Homo sapiens] [gi:8574038] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 81065467 | | CID | 42628053 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 activated mutant | | AID | 2048 | | BioAssay type | confirmatory | | Target | Rac1 protein [Homo sapiens] [gi:8574038] | | PubMed | | | Data Table |  |
|
| 23 | [SID81065467] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 activated mutant [AID2048, Type: confirmatory] | Rac1 protein [Homo sapiens] [gi:8574038] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 81065467 | | CID | 42628053 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac1 activated mutant | | AID | 2048 | | BioAssay type | confirmatory | | Target | Rac1 protein [Homo sapiens] [gi:8574038] | | PubMed | | | Data Table |  |
|
| 24 | [SID81065467] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype [AID2047, Type: confirmatory] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 81065467 | | CID | 42628053 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype | | AID | 2047 | | BioAssay type | confirmatory | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 25 | [SID81065467] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype [AID2047, Type: confirmatory] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 81065467 | | CID | 42628053 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype | | AID | 2047 | | BioAssay type | confirmatory | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 26 | [SID81065467] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype [AID2047, Type: confirmatory] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 81065467 | | CID | 42628053 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype | | AID | 2047 | | BioAssay type | confirmatory | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 27 | [SID81065467] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras activated mutant [AID2050, Type: confirmatory] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 81065467 | | CID | 42628053 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras activated mutant | | AID | 2050 | | BioAssay type | confirmatory | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 28 | [SID81065467] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras activated mutant [AID2050, Type: confirmatory] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 81065467 | | CID | 42628053 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras activated mutant | | AID | 2050 | | BioAssay type | confirmatory | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 29 | [SID81065467] | Inactive | EC50 | 30 | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras activated mutant [AID2050, Type: confirmatory] | ras protein [Homo sapiens] [gi:190938] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 81065467 | | CID | 42628053 | | Outcome | Inactive | | EC50 | 30 [uM] | | BioAssay | Pyrazoline SAR compounds tested via Multiplex dose response to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras activated mutant | | AID | 2050 | | BioAssay type | confirmatory | | Target | ras protein [Homo sapiens] [gi:190938] | | PubMed | | | Data Table |  |
|
| 30 | [SID87349043] | Inactive | Potency | 31.6228 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 31 | [SID87349043] | Inactive | Potency | 35.4813 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID87349043] | Inactive | Potency | 44.6684 | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails [AID540317, Type: confirmatory] | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | Potency | 44.6684 [uM] | | BioAssay | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails | | AID | 540317 | | BioAssay type | confirmatory | | Target | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] | | PubMed | | | Data Table |  |
|
| 33 | [SID87349043] | Inactive | Potency | 44.6684 | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 34 | [SID87349043] | Inactive | Potency | 44.6684 | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 35 | [SID87349043] | Inactive | Potency | 89.1251 | qHTS Assay to Find Inhibitors of Pin1 [AID504891, Type: confirmatory] | PIN1 gene product [Homo sapiens] [gi:5453898] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS Assay to Find Inhibitors of Pin1 | | AID | 504891 | | BioAssay type | confirmatory | | Target | PIN1 gene product [Homo sapiens] [gi:5453898] | | PubMed | | | Data Table |  |
|
| 36 | [SID87349043] | Inactive | Potency | 89.1251 | qHTS Assay to Find Inhibitors of Pin1 [AID504891, Type: confirmatory] | PIN1 gene product [Homo sapiens] [gi:5453898] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS Assay to Find Inhibitors of Pin1 | | AID | 504891 | | BioAssay type | confirmatory | | Target | PIN1 gene product [Homo sapiens] [gi:5453898] | | PubMed | | | Data Table |  |
|
| 37 | [SID87349043] | Inactive | Potency | | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) [AID652105, Type: confirmatory] | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) | | AID | 652105 | | BioAssay type | confirmatory | | Target | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] | | PubMed | | | Data Table |  |
|
| 38 | [SID87349043] | Inactive | Potency | | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 39 | [SID87349043] | Inactive | Potency | | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 40 | [SID87349043] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex [AID504700, Type: screening] | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex | | AID | 504700 | | BioAssay type | screening | | Target | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] | | PubMed | | | Data Table |  |
|
| 41 | [SID87349043] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex [AID504700, Type: screening] | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex | | AID | 504700 | | BioAssay type | screening | | Target | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] | | PubMed | | | Data Table |  |
|
| 42 | [SID87349043] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex [AID504700, Type: screening] | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex | | AID | 504700 | | BioAssay type | screening | | Target | cAMP-dependent protein kinase catalytic subunit beta isoform 3 [Homo sapiens] [gi:46909587] | | PubMed | | | Data Table |  |
|
| 43 | [SID87349043] | Inactive | | | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen [AID652039, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 652039 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 44 | [SID87349043] | Inactive | | | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen [AID652039, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 652039 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 45 | [SID87349043] | Inactive | | | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID651710, Type: screening] | RAD52 gene product [Homo sapiens] [gi:109637798] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | BioAssay | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 651710 | | BioAssay type | screening | | Target | RAD52 gene product [Homo sapiens] [gi:109637798] | | PubMed | | | Data Table |  |
|
| 46 | [SID87349043] | Inactive | | | qHTS Assay for Inhibitors of the CtBP/E1A Interaction [AID651724, Type: screening] | CtBP interacting protein CtIP [Homo sapiens] [gi:1730321] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of the CtBP/E1A Interaction | | AID | 651724 | | BioAssay type | screening | | Target | CtBP interacting protein CtIP [Homo sapiens] [gi:1730321] | | PubMed | | | Data Table |  |
|
| 47 | [SID87349043] | Inactive | Potency | | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS [AID504845, Type: confirmatory] | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS | | AID | 504845 | | BioAssay type | confirmatory | | Target | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] | | PubMed | | | Data Table |  |
|
| 48 | [SID87349043] | Inactive | Potency | | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS [AID504845, Type: confirmatory] | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS | | AID | 504845 | | BioAssay type | confirmatory | | Target | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] | | PubMed | | | Data Table |  |
|
| 49 | [SID87349043] | Inactive | Potency | | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS [AID504845, Type: confirmatory] | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS | | AID | 504845 | | BioAssay type | confirmatory | | Target | regulator of G-protein signaling 4 [Homo sapiens] [gi:86301163] | | PubMed | | | Data Table |  |
|
| 50 | [SID87349043] | Inactive | | | S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity [AID652163, Type: screening] | S100A4 [Homo sapiens] [gi:47496637] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 87349043 | | CID | 42628053 | | Outcome | Inactive | | BioAssay | S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652163 | | BioAssay type | screening | | Target | S100A4 [Homo sapiens] [gi:47496637] | | PubMed | | | Data Table |  |
|